These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33528719)

  • 1. The Interface of Therapeutics and Genomics in Cardiovascular Medicine.
    Magavern EF; Kaski JC; Turner RM; Janmohamed A; Borry P; Pirmohamed M
    Cardiovasc Drugs Ther; 2021 Jun; 35(3):663-676. PubMed ID: 33528719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics to Revive Drug Development in Cardiovascular Disease.
    Dubé MP; de Denus S; Tardif JC
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):59-64. PubMed ID: 26768480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
    Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
    Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding role of pharmacogenomics in the management of cardiovascular disorders.
    Yip VL; Pirmohamed M
    Am J Cardiovasc Drugs; 2013 Jun; 13(3):151-62. PubMed ID: 23579966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision medicine in cardiovascular therapeutics: Evaluating the role of pharmacogenetic analysis prior to drug treatment.
    Ingelman-Sundberg M; Pirmohamed M
    J Intern Med; 2024 May; 295(5):583-598. PubMed ID: 38343077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical translation of cell-based pharmacogenomic discovery.
    Cox NJ; Gamazon ER; Wheeler HE; Dolan ME
    Clin Pharmacol Ther; 2012 Oct; 92(4):425-7. PubMed ID: 22910437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role and impact of SNPs in pharmacogenomics and personalized medicine.
    Laing RE; Hess P; Shen Y; Wang J; Hu SX
    Curr Drug Metab; 2011 Jun; 12(5):460-86. PubMed ID: 21453271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics: Driving Personalized Medicine.
    Sadee W; Wang D; Hartmann K; Toland AE
    Pharmacol Rev; 2023 Jul; 75(4):789-814. PubMed ID: 36927888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of cardiovascular drugs.
    Saleh A; Al-Abcha A; Pereira N
    Curr Opin Cardiol; 2023 May; 38(3):207-214. PubMed ID: 37016993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unveiling the guidance heterogeneity for genome-informed drug treatment interventions among regulatory bodies and research consortia.
    Koutsilieri S; Tzioufa F; Sismanoglou DC; Patrinos GP
    Pharmacol Res; 2020 Mar; 153():104590. PubMed ID: 31830522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of Pharmacogenomics in Precision Medicine.
    Cascorbi I
    Clin Pharmacol Ther; 2018 May; 103(5):732-735. PubMed ID: 29660122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments and future directions for the use of pharmacogenomics in cardiovascular disease treatments.
    Berinstein E; Levy A
    Expert Opin Drug Metab Toxicol; 2017 Sep; 13(9):973-983. PubMed ID: 28792790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular pharmacogenomics.
    Roden DM; Johnson JA; Kimmel SE; Krauss RM; Medina MW; Shuldiner A; Wilke RA
    Circ Res; 2011 Sep; 109(7):807-20. PubMed ID: 21921273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.
    Mango R; Vecchione L; Raso B; Borgiani P; Brunetti E; Mehta JL; Lauro R; Romeo F; Novelli G
    Expert Opin Pharmacother; 2005 Dec; 6(15):2565-76. PubMed ID: 16316297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics, precision medicine, and implications for anesthesia care.
    Kaye AD; Mahakian T; Kaye AJ; Pham AA; Hart BM; Gennuso S; Cornett EM; Gabriel RA; Urman RD
    Best Pract Res Clin Anaesthesiol; 2018 Jun; 32(2):61-81. PubMed ID: 30322465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics, pharmacogenomics, and individualized medicine.
    Ma Q; Lu AY
    Pharmacol Rev; 2011 Jun; 63(2):437-59. PubMed ID: 21436344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.
    Zaiou M; El Amri H
    Clin Genet; 2017 Mar; 91(3):355-370. PubMed ID: 27714756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing outcomes and costs among warfarin-sensitive patients versus warfarin-insensitive patients using The Right Drug, Right Dose, Right Time: Using genomic data to individualize treatment (RIGHT) 10K warfarin cohort.
    Swanson KM; Zhu Y; Rojas RL; St Sauver JL; Bielinski SJ; Jacobsen DJ; Visscher SL; Wang L; Weinshilboum R; Borah BJ
    PLoS One; 2020; 15(5):e0233316. PubMed ID: 32428022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering next-generation pharmacogenomics: an information technology perspective.
    Potamias G; Lakiotaki K; Katsila T; Lee MT; Topouzis S; Cooper DN; Patrinos GP
    Open Biol; 2014 Jul; 4(7):. PubMed ID: 25030607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol.
    Bielinski SJ; Olson JE; Pathak J; Weinshilboum RM; Wang L; Lyke KJ; Ryu E; Targonski PV; Van Norstrand MD; Hathcock MA; Takahashi PY; McCormick JB; Johnson KJ; Maschke KJ; Rohrer Vitek CR; Ellingson MS; Wieben ED; Farrugia G; Morrisette JA; Kruckeberg KJ; Bruflat JK; Peterson LM; Blommel JH; Skierka JM; Ferber MJ; Black JL; Baudhuin LM; Klee EW; Ross JL; Veldhuizen TL; Schultz CG; Caraballo PJ; Freimuth RR; Chute CG; Kullo IJ
    Mayo Clin Proc; 2014 Jan; 89(1):25-33. PubMed ID: 24388019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.